Francisco Javier Basterra-Gortari1, Maira Bes-Rastrollo2, Miguel Ruiz-Canela2, Alfredo Gea2, Miguel Ángel Martinez-Gonzalez3. 1. Departamento de Medicina Interna (Endocrinología), Hospital Reina Sofía, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Servicio Navarro de Salud-Osasunbidea, Tudela, Navarra, España; Universidad de Navarra, Departamento de Medicina Preventiva y Salud Pública, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Navarra, España. 2. Universidad de Navarra, Departamento de Medicina Preventiva y Salud Pública, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Navarra, España; Centro de Investigación Biomédica en Red de la Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Madrid, España. 3. Universidad de Navarra, Departamento de Medicina Preventiva y Salud Pública, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Navarra, España; Centro de Investigación Biomédica en Red de la Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Madrid, España. Electronic address: mamartinez@unav.es.
Abstract
BACKGROUND AND OBJECTIVE: The prevalence of obesity and diabetes mellitus (DM) has increased worldwide. Our objective was to examine trends in the prevalence of overweight, obesity, morbid obesity and DM in Spain from 1987 to 2012. PARTICIPANTS AND METHODS: Data were obtained from 8 waves of the national health surveys which are cross-sectional studies conducted in representative samples of the Spanish adult population. Self-reported data of 156,440 adults (≥16 years) from 1987 to 2012 were used. Body mass index (BMI) was calculated from self-reported weight and height. Overweight was defined as a BMI of 25.0 to 29.9kg/m2, obesity as a BMI≥30kg/m2 and morbid obesity as a BMI≥40kg/m2. DM was considered present if the participant reported having been diagnosed. Age-adjusted prevalence was adjusted by the direct standardisation method to the 2003 survey population. RESULTS: From 1987 to 2012 age-adjusted prevalence of overweight increased from 34.0% (95% confidence interval [95% CI] 33.2-34.8) to 35.8% (95% CI 35.0-36.6), prevalence of obesity from 8.0% (95% CI 7.5-8.5) to 16.5% (95% CI 15.7-17.1%) and DM prevalence from 4.2% (95% CI 3.9-4.5) to 7.1% (95% CI 6.7-7.4%). Morbid obesity increased from 0.20% (95% CI 0.13-0.27) in 1993 to 0.88% (95% CI 0.70-1.05) in 2012. The growth rate was greater among males. CONCLUSIONS: An increasing trend of the prevalence of overweight, obesity, morbid obesity and DM was found in Spain from 1987 to 2012, particularly in males.
BACKGROUND AND OBJECTIVE: The prevalence of obesity and diabetes mellitus (DM) has increased worldwide. Our objective was to examine trends in the prevalence of overweight, obesity, morbid obesity and DM in Spain from 1987 to 2012. PARTICIPANTS AND METHODS: Data were obtained from 8 waves of the national health surveys which are cross-sectional studies conducted in representative samples of the Spanish adult population. Self-reported data of 156,440 adults (≥16 years) from 1987 to 2012 were used. Body mass index (BMI) was calculated from self-reported weight and height. Overweight was defined as a BMI of 25.0 to 29.9kg/m2, obesity as a BMI≥30kg/m2 and morbid obesity as a BMI≥40kg/m2. DM was considered present if the participant reported having been diagnosed. Age-adjusted prevalence was adjusted by the direct standardisation method to the 2003 survey population. RESULTS: From 1987 to 2012 age-adjusted prevalence of overweight increased from 34.0% (95% confidence interval [95% CI] 33.2-34.8) to 35.8% (95% CI 35.0-36.6), prevalence of obesity from 8.0% (95% CI 7.5-8.5) to 16.5% (95% CI 15.7-17.1%) and DM prevalence from 4.2% (95% CI 3.9-4.5) to 7.1% (95% CI 6.7-7.4%). Morbid obesity increased from 0.20% (95% CI 0.13-0.27) in 1993 to 0.88% (95% CI 0.70-1.05) in 2012. The growth rate was greater among males. CONCLUSIONS: An increasing trend of the prevalence of overweight, obesity, morbid obesity and DM was found in Spain from 1987 to 2012, particularly in males.
Authors: Carmen Pérez-Rodrigo; Marta Gianzo-Citores; Ángel Gil; Marcela González-Gross; Rosa M Ortega; Lluis Serra-Majem; Gregorio Varela-Moreiras; Javier Aranceta-Bartrina Journal: Nutrients Date: 2017-06-14 Impact factor: 5.717
Authors: María de Lourdes Samaniego-Vaesken; Teresa Partearroyo; Emma Ruiz; Javier Aranceta-Bartrina; Ángel Gil; Marcela González-Gross; Rosa M Ortega; Lluis Serra-Majem; Gregorio Varela-Moreiras Journal: Nutrients Date: 2018-03-22 Impact factor: 5.717
Authors: José Ignacio Baile; Raquel María Guevara; María José González-Calderón; José David Urchaga Journal: Int J Environ Res Public Health Date: 2020-04-29 Impact factor: 3.390
Authors: Naomi Cano-Ibáñez; Aurora Bueno-Cavanillas; Miguel A Martínez-González; Dolores Corella; Jordi Salas-Salvadó; M Dolors Zomeño; Manoli García-de-la-Hera; Dora Romaguera; J Alfredo Martínez; F Javier Barón-López; Antonio García-Ríos; Ramón Estruch; Laura García-Molina; Ángel Alonso Gómez; Josep A Tur; Francisco Tinahones; Lluis Serra-Majem; Naiara Cubelos-Fernández; José Lapetra; Clotilde Vázquez; Xavier Pintó; Josep Vidal; Lidia Daimiel; José Juan Gaforio; Pilar Matía; Emilio Ros; Javier Diez-Espino; Rebeca Fernández-Carrión; Josep Basora; Montse Fitó; Juan Manuel Zazo; Antoni Colom; Estefanía Toledo; Andrés Díaz-López; Miguel Ángel Muñoz; Miguel Ruiz-Canela; Alfredo Gea Journal: Nutrients Date: 2018-11-04 Impact factor: 5.717
Authors: Julia Díez; Pedro Gullón; María Sandín Vázquez; Belén Álvarez; María Del Prado Martín; María Urtasun; Maite Gamarra; Joel Gittelsohn; Manuel Franco Journal: Int J Environ Res Public Health Date: 2018-03-30 Impact factor: 3.390
Authors: Ana López-de-Andrés; Napoleón Perez-Farinos; Valentín Hernández-Barrera; María A Palomar-Gallego; David Carabantes-Alarcón; José J Zamorano-León; Javier de Miguel-Diez; Rodrigo Jimenez-Garcia Journal: J Clin Med Date: 2020-02-21 Impact factor: 4.241
Authors: José M de Miguel-Yanes; Rodrigo Jiménez-García; Valentín Hernández-Barrera; Javier de Miguel-Díez; Manuel Méndez-Bailón; Nuria Muñoz-Rivas; Napoleón Pérez-Farinós; Ana López-de-Andrés Journal: Cardiovasc Diabetol Date: 2019-11-21 Impact factor: 9.951